DuPont Water Solutions has announced a major transformation of the OxyMem membrane aerated biofilm reactor (MABR) at its manufacturing facility in Athlone, Ireland. The investment in the facilities and employees at the Athlone site will help meet the increasing global demand for MABR.
This investment includes additional training for staff based on Athlone and is supported by the Irish Government through IDA Ireland.
Ireland Minister for Trade Promotion, Digital and Company Regulation Robert Troy, said: “As we look to a post-pandemic recovery, ensuring balanced regional enterprise development is key and the announcement of DuPont’s multimillion-euro investment at their site in Athlone is indicative of their continued success in Athlone, and indeed a testament to the Midlands region as a great place to do business.
“This investment will have a transformative impact for the site and the staff, who will all benefit from upskilling. I was delighted to have the opportunity to visit the facility and see first-hand the work being undertaken there.”
OxyMem was one of the first companies to commercialise MABR technology, which supports secondary wastewater treatment. DuPont acquired OxyMem in 2019, expanding its extensive portfolio of water solutions that help produce, purify and extract some of the world’s most commercially important products.
Andreas Gorenflo, general manager of OxyMem, added: “This investment will allow OxyMem to develop more efficient and reliable production technology as well as improve our product design to meet the continuously increasing demand by the market. It is fundamentally important and it will help us grow the company to meet the increasing global demand for MABR.”
